- バイオンテック
- ワクチン
- 開発
- 新型コロナウイルス
- 新型肺炎
- アンソニー
- ダイク
- ドイツ
- バロック
- バン
「プファルツ」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- ビジネス
- 色
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 0
- 期間を指定 48
- 日付指定なし 48
- 種類
- 写真 48
- グラフィックス 0
- 映像 0
- 向き
- 縦 5
- 横 43
- 正方形 0
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 48
- モノクロ 0
- 新しい順
- 1
- 新しい順
2021年02月01日Coronavirus - Search for the British Mutant01 February 2021, Rhineland-Palatinate, Ingelheim: Oliver Harzer, MD, Managing Director/CEO Bioscientia Institut für Medizinische Diagnostik GmbH, stands at a machine for sequencing PCR tests. The British coroanvirus mutant B.1.1.7 is increasingly spreading. The company Bioscientia, one of the largest laboratories in Germany, is using automated sequencing machines to help with the analysis. (to “Time-consuming and highly complex: The search for the B.1.1.7 mutant“) Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021020308226
2020年11月25日DB-Lok promotes diversity25 November 2020, Rhineland-Palatinate, Mainz: Tijen Onaran, CEO ＆ founder of GDW Global Digital Women GmbH and initiator of the award, stands in front of the specially designed locomotive and makes a selfie. The company Deutsche Bahn Cargo has unveiled a locomotive in the design of the “Digital Female Leader Award“, which is intended to act as a visible sign of diversity. The annual award is given to women who are shaping digitisation. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020112605249
2020年09月22日Federal Minister of Health visits Boehringer Ingelheim22 September 2020, Rhineland-Palatinate, Ingelheim am Rhein: Jens Spahn (CDU), Federal Minister of Health, puts on VR glasses during his visit to the pharmaceutical company Boehringer Ingelheim. Accompanied by the leader of the CDU parliamentary group in Rhineland-Palatinate, the Federal Minister of Health is visiting the companies Boehringer Ingelheim and Bioscientia Healthcare GmbH. The visits will focus on the current status of the search for a drug against Covid-19. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020092506697
2020年09月22日Federal Minister of Health visits Boehringer Ingelheim22 September 2020, Rhineland-Palatinate, Ingelheim am Rhein: Jens Spahn (CDU), Federal Minister of Health, puts on VR glasses during his visit to the pharmaceutical company Boehringer Ingelheim. Accompanied by the leader of the CDU parliamentary group in Rhineland-Palatinate, the Federal Minister of Health is visiting the companies Boehringer Ingelheim and Bioscientia Healthcare GmbH. The visits will focus on the current status of the search for a drug against Covid-19. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020092506719
2020年09月22日Federal Minister of Health visits Bioscientia Healthcare22 September 2020, Rhineland-Palatinate, Ingelheim am Rhein: Oliver Harzer (l), CEO of Bioscientia Healthcare GmbH, and Jens Spahn (CDU), Federal Minister of Health, walking through the company‘s laboratory together. Bioscientia Healthcare carries out COVID-19 tests, among other things. Accompanied by the leader of the CDU parliamentary group in Rhineland-Palatinate, the Federal Minister of Health will visit the companies Boehringer Ingelheim and Bioscientia Healthcare GmbH. The visits will focus on the current status of the search for a drug against Covid-19. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020092506673
2020年09月22日Hubertus von Baumbach from Boehringer Ingelheim22 September 2020, Rhineland-Palatinate, Ingelheim am Rhein: Hubertus von Baumbach, Chairman and CEO of Boehringer Ingelheim, stands on the company premises. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020092600605
2020年08月26日Progroup AG puts new plant into operation26 August 2020, Saxony-Anhalt, Sandersdorf-Brehna: Jürgen Heindl, CEO of Progroup AG, stands in front of the paper machine in the new mill of Progroup Paper PM3 GmbH. The Progroup AG from Landau in der Pfalz has invested around 465 million euros in the location in Saxony-Anhalt. The heart of the factory with 140 new jobs is the paper machine for the production of corrugated base paper. Around 860,000 tonnes of recovered paper are processed into corrugated board every year. The plant is currently being commissioned and has an annual capacity of 750,000 tonnes. According to the Ministry of Economics, the plant is one of the largest investments in the state since reunification. Photo: Hendrik Schmidt/dpa-Zentralbild/ZB、クレジット：ＺＢ／ＤＰＡ／共同通信イメージズ
商品コード: 2020082706680
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Michael Lohscheller, CEO Opel Automobile GmbH, and the Prime Minister of Rhineland-Palatinate, Malu Dreyer (SPD), sit in front of the Opel logo. At a press conference Opel presented the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004367
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Michael Lohscheller, CEO Opel Automobile GmbH, and Federal Minister of Economics Peter Altmaier (CDU, l) sit next to each other at a press conference. Opel will present the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004312
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Michael Lohscheller, CEO Opel Automobile GmbH, looks into the camera. At a press conference Opel presented the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004332
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Klaus Weichel (l-r), Lord Mayor of Kaiserslautern, Peter Altmaier (CDU), Federal Minister of Economics and Michael Lohscheller, CEO Opel Automobile GmbH, sit next to each other at a press conference. Opel will present the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004140
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Thorsten Zangerle (l-r), Chairman of the Opel Kaiserslautern Works Council, Klaus Weichel, Lord Mayor of Kaiserslautern, Volker Wissing (FDP), Rhineland-Palatinate Minister of Economics, Rhineland-Palatinate Premier Malu Dreyer (SPD), Michael Lohscheller, CEO Opel Automobile GmbH, and Federal Minister of Economics Peter Altmaier (CDU) stand next to an electric Opel Corsa. At a press conference Opel presented the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004318
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Rhineland-Palatinate Premier Malu Dreyer (SPD, l-r), Michael Lohscheller, CEO Opel Automobile GmbH, and Federal Minister of Economics Peter Altmaier (CDU) stand next to an electric Opel Corsa. At a press conference Opel presented the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004400
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Michael Lohscheller, CEO Opel Automobile GmbH, and the Prime Minister of Rhineland-Palatinate, Malu Dreyer (SPD), are talking. At a press conference Opel presented the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004235
2020年02月07日Opel press event on battery cell production07 February 2020, Rhineland-Palatinate, Kaiserslautern: Michael Lohscheller, CEO Opel Automobile GmbH, sits in front of the Opel logo. At a press conference Opel presented the planned battery cell production in Kaiserslautern. Photo: Oliver Dietze/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2020021004224
2019年11月27日Biotechnology company BioNTech27 November 2019, Rhineland-Palatinate, Mainz: Ugur Sahin, CEO BioNTech, gesticulated during the interview. BioNTech is a biotechnology company focused on developing and manufacturing a patient-specific approach for the treatment of cancer and other serious diseases. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019121501632
2019年11月27日Biotechnology company BioNTech27 November 2019, Rhineland-Palatinate, Mainz: Sean Marett (l), CFO BioNTech, and Ugur Sahin, CEO BioNTech, stand side by side. BioNTech is a biotechnology company focused on developing and manufacturing a patient-specific approach for the treatment of cancer and other serious diseases. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019121501435
2019年11月27日Biotechnology company BioNTech27 November 2019, Rhineland-Palatinate, Mainz: Sean Marett (l), CFO BioNTech, and Ugur Sahin, CEO BioNTech, sit next to each other during the interview. BioNTech is a biotechnology company focused on developing and manufacturing a patient-specific approach for the treatment of cancer and other serious diseases. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019121501400
2019年11月27日Biotechnology company BioNTech27 November 2019, Rhineland-Palatinate, Mainz: Sean Marett (l), CFO BioNTech, and Ugur Sahin, CEO BioNTech, sit next to each other during the interview. BioNTech is a biotechnology company focused on developing and manufacturing a patient-specific approach for the treatment of cancer and other serious diseases. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019121501384
2019年11月27日Biotechnology company BioNTech27 November 2019, Rhineland-Palatinate, Mainz: Ugur Sahin, CEO BioNTech, gesticulated during the interview. BioNTech is a biotechnology company focused on developing and manufacturing a patient-specific approach for the treatment of cancer and other serious diseases. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019121501633
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on a podium in front of the journalists. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042303727
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits in front of a background projection of pharmaceutical products. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811817
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on the podium before the press conference. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811842
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, Chairman and CEO of Boehringer Ingelheim, sits on the podium laughing. The pharmaceutical company presents a balance sheet for 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042401717
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on a podium in front of the journalists. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042303708
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on the podium gesticulating. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811855
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on a podium in front of the journalists. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042303823
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on a podium in front of the journalists. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042303852
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits in front of a background projection of pharmaceutical products. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811774
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: The name of Hubertus von Baumbach, Chairman and CEO of Boehringer Ingelheim, is written in his place at the press conference. The pharmaceutical company presents a balance sheet for 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042402020
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on the podium gesticulating. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811946
2019年04月17日Balance Sheet-Pk at Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits in front of a background projection of pharmaceutical products. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019042303717
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits in front of a background projection of pharmaceutical products. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811773
2019年04月17日Pharmaceutical company Boehringer Ingelheim17 April 2019, Rhineland-Palatinate, Ingelheim: Hubertus von Baumbach, CEO, sits on the podium gesticulating. The pharmaceutical company Boehringer Ingelheim presents a balance sheet for the year 2018 and presents digital projects from research, patient care and the world of work. Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041811566
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, talks in her office on the sidelines of an interview with the German Press Agency. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041216380
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, stands in her office on the edge of an interview with the German Press Agency with a view of the company premises. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041216381
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, talks in her office on the sidelines of an interview with the German Press Agency. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041216548
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim De08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, talks in her office on the sidelines of an interview with the German Press Agency. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041217665
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, talks in her office on the sidelines of an interview with the German Press Agency. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041217677
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, stands in her office on the edge of an interview with the German Press Agency with a view of the company premises. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041216689
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since the beginning of 2019, stands in her office on the edge of an interview with the German Press Agency with a view of the company premises. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041217692
2019年04月08日Sabine Nikolaus - Boehringer Ingelheim08 April 2019, Rhineland-Palatinate, Ingelheim: Sabine Nikolaus, CEO of Boehringer Ingelheim Deutschland GmbH since early 2019, sits at her desk in her office on the edge of an interview with the German Press Agency. Photo: Frank Rumpenhorst/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019041217675
2018年11月16日Federal Assembly of Representatives KPV16 November 2018, Rhineland-Palatinate, Koblenz: The candidates for the CDU presidency, former head of the CDU parliamentary group Friedrich Merz (all CDU, l-r), Secretary General Annegret Kramp-Karrenbauer, Health Minister Jens Spahn and KPV Federal Chairman Christian Haase (2nd vr) will speak at the Federal Representatives‘ Assembly of the Association of Local Authorities. Photo: Thomas Frey/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2018112200519
2018年11月16日Federal Assembly of Representatives KPV16 November 2018, Rhineland-Palatinate, Koblenz: The candidates for the CDU presidency, former head of the CDU parliamentary group Friedrich Merz (all CDU, l-r), Secretary General Annegret Kramp-Karrenbauer, Health Minister Jens Spahn and KPV Federal Chairman Christian Haase (2nd vr) will speak at the Federal Representatives‘ Assembly of the Association of Local Authorities. Photo: Thomas Frey/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2018112200863
2018年11月16日Federal Assembly of Representatives KPV16 November 2018, Rhineland-Palatinate, Koblenz: The candidates for the CDU presidency, former head of the CDU parliamentary group Friedrich Merz (all CDU, l-r), Secretary General Annegret Kramp-Karrenbauer, Health Minister Jens Spahn and KPV Federal Chairman Christian Haase (2nd vr) will speak at the Federal Representatives‘ Assembly of the Association of Local Authorities. Photo: Thomas Frey/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2018112200595
2018年11月16日Federal Assembly of Representatives KPV16 November 2018, Rhineland-Palatinate, Koblenz: The candidates for the CDU presidency, former head of the CDU parliamentary group Friedrich Merz (all CDU, l-r), Secretary General Annegret Kramp-Karrenbauer, Health Minister Jens Spahn and KPV Federal Chairman Christian Haase (2nd vr) will speak at the Federal Representatives‘ Assembly of the Association of Local Authorities. Photo: Thomas Frey/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2018112200672
2017年11月23日Thyssenkrupp to cut 6000 jobsFILED - 23 November 2017, Rhineland-Palatinate, Andernach: Steel workers demonstrate in Andernach against the planned merger of the steel companies Thyssenkrupp and Tata. The industrial group Thyssenkrupp wants to cut 6000 jobs after the steel merger with Indian competitor Tata burst. Of these, 4000 jobs are in Germany, said CEO Kerkhoff on 10.05.2019. Photo: Thomas Frey/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019051605793
-Frederick V, King of Bohemia, Elector Palatine, died 1632.Frederick V, King of Bohemia, Elector Palatine, died 1632. Copperplate mezzotint by Robert Dunkarton after an original painting by Anthony van Dyck from Samuel Woodburn‘s Portraits of Characters Illustrious in British History, London, 1812.、クレジット：Ａｌｂｕｍ／Ｆｌｏｒｉｌｅｇｉｕｓ／共同通信イメージズ ※エディトリアル使用のみ。表紙、広告、プロモーション、商業目的での利用はお問合せください。クレジットは必ず表記してください。※「顔写真」対象外の商品です。
商品コード: 2020032601790
- 1
